City Hill Ventures, LLC to Present at 2012 Business Development Biotech Conference, April 17

Jonathan Lim, M.D., Managing Partner and Founder of City Hill Ventures, LLC, a health care focused venture capital firm, is one of the over 40 life science leaders invited to speak at the 2012 Business Development Biotech Conference, held April 17 and 18 at the Mandarin Hotel in Boston. Other conference speakers include Mikael Dolsten, M.D., Ph.D., President, Pfizer Worldwide Research and Development; Jim Greenwood, President & CEO, Biotechnology Industry Organization; Harvard University Professor Larry Summers, Ph.D.; and Anne Wojcicki, co-founder, 23andMe.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

San Diego, CA (PRWEB) April 16, 2012

City Hill Ventures, LLC (http://cityhillventures.com/index.php) announced today that Jonathan Lim, M.D., Managing Partner and Founder, is one of the over 40 life science leaders invited to speak at the 2012 Business Development Biotech Conference, held April 17 and 18 at the Mandarin Hotel in Boston.

Speakers also will include Christoph Boehringer, Ph.D., co-founder of Mediatum and CD-Venture; Josh Boger, Ph.D., founder, Vertex Pharmaceuticals; Mikael Dolsten, M.D., Ph.D., President, Pfizer Worldwide Research and Development; Jim Greenwood, President & CEO, Biotechnology Industry Organization; Marc Tessier Lavigne, Ph.D., Rockefeller University President; Harvard University Professor Larry Summers, Ph.D.; and Anne Wojcicki, co-founder, 23andMe.

The conference is an exclusive networking forum for industry CEOs and heads of business development that offers access to the key decision makers in life sciences. Leaders in venture capital, strategic consulting and private equity will also attend.

Dr. Lim, who created the health care focused venture capital firm City Hill Ventures in 2010, is the former President, CEO and Board Director of Halozyme Therapeutics, Inc. During his leadership of Halozyme from 2003 to 2010, the company grew from five employees and a market value of $5 million to 140 employees and a peak market capitalization of nearly $1 billion. His bio is posted at: http://cityhillventures.com/team.php.

In the conference session on “The West Coast Perspective,” Dr. Lim will comment on strategy related topics such as financing, business development, and company formation. He will also provide his perspective on the San Diego region’s highly entrepreneurial and productive biomedical community, which includes numerous life science companies, as well as several of the world’s leading academic research institutions.

Also speaking during the “West Coast Perspective” session will be officials of Onyx Pharmaceuticals, Regulus Therapeutics, and 23andme. All conference speakers are listed at: http://bit.ly/HsyzWu.

City Hill Ventures, LLC
http://cityhillventures.com/index.php

Inspired by Matthew 5:14, Jonathan Lim, M.D., established City Hill Ventures in 2010 to build a San Diego based investment firm that could have a positive impact on health care.

“At City Hill Ventures, we are entrepreneurs at heart,” said Dr. Lim. “Our mission is to restore human health through innovation, by building or helping other health care entrepreneurs build great companies that collectively have a transformative impact on patients, the health care industry, and society.”

City Hill Ventures’ current portfolio (http://cityhillventures.com/portfolio.php) includes: Eclipse Therapeutics, Inc., Independa, Inc., Inhibrx, Inc., NexDx, Inc., and Medenovo, LLC.


Contact

  • Cathy Yarbrough

    (858) 243-1814
    Email